Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
James N. Topper's stake in Eledon Pharmaceuticals, Inc. fell to 2.00% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
James N. Topper's stake in Eledon Pharmaceuticals, Inc. fell to 2.00%, 1,176,735 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 2.00%
- Shares
- 1,176,735
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 17 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 1.50% | 878,080 |
| FHMLSP, L.P. | 1.50% | 878,080 |
| FHMLSP, L.L.C. | 1.50% | 878,080 |
| Frazier Life Sciences Public Overage Fund, L.P. | 0.40% | 258,998 |
| FHMLSP Overage, L.P. | 0.40% | 258,998 |
| FHMLSP Overage, L.L.C. | 0.40% | 258,998 |
| Frazier Life Sciences X, L.P. | 0% | 13,062 |
| FHMLS X, L.P. | 0% | 13,062 |
| FHMLS X, L.L.C. | 0% | 13,062 |
| Frazier Life Sciences XI, L.P. | 0% | 26,595 |
| FHMLS XI, L.P. | 0% | 26,595 |
| FHMLS XI, L.L.C. | 0% | 26,595 |
| James N. Topper | 2.00% | 1,176,735 |
| Patrick J. Heron | 2.00% | 1,176,735 |
| Albert Cha | 1.90% | 1,137,078 |
| James Brush | 1.90% | 1,137,078 |
| Daniel Estes | 0% | 26,595 |
Source
Related
- Eledon Pharmaceuticals, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Eledon Pharmaceuticals, Inc. shareholders
- Form 4 · Gros David-Alexandre C · Aug 4, 2026
- Form 4 · Perrin Steven · Aug 4, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026